Effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg: A randomized, open-label, crossover, single-centre study

Clinical Drug Investigation

Volumn 29, Issue 3, 2009, Pages 145-152

  Darwish, Mona ^a   Xie, Fang ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMRIX; CYCLOBENZAPRINE; UNCLASSIFIED DRUG;

ADULT; AFFINITY CHROMATOGRAPHY; APHTHOUS STOMATITIS; AREA UNDER THE CURVE; ARTICLE; CONTACT DERMATITIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFECT; DRUG ELIMINATION; DRUG FATALITY; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; DRUG WITHDRAWAL; DYSESTHESIA; FATIGUE; FEMALE; FOOD; FOOD INTAKE; HERPES SIMPLEX; HUMAN; INSOMNIA; LIMB PAIN; MALE; MORNING DOSAGE; NAUSEA; NORMAL HUMAN; PAPULAR RASH; PARESTHESIA; PRIORITY JOURNAL; SINGLE DRUG DOSE; STOMATITIS; SYNCOPE; TONSILLITIS; WEAKNESS;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; FOOD-DRUG INTERACTIONS; HALF-LIFE; HUMANS; MALE; SAMPLE SIZE; YOUNG ADULT;

EID: 61349141812     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200929030-00001     Document Type: Article

References (17)

1. van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003; 4 (2): CD004252
2. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004 Aug; 28 (2): 140-75
3. Cyclobenzaprine hydrochloride tablets [package insert]. Corona (CA): Watson Laboratories, Inc., 2006
4. Darwish M, Hellriegel ET, Xie F. Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults: a randomized, open-label, two-period crossover, single-centre study. Clin Drug Invest 2008; 28 (12): 793-801
5. Weil A, Narayana A, Chang SCK, et al. Efficacy of cyclobenzaprine hydrochloride extended-release 15 mg and 30 mg once-daily for low back and neck pain associated with muscle spasms: a pooled analysis of two randomized, double-blind, parallel-group, placebo-controlled, multicenter studies [abstract no. 206]. Pain Med 2008; 9 (1): 134-5
6. Weil AJ, Altman C, Chang SCK, et al. Efficacy of cyclobenzaprine hydrochloride extended-release 15 and 30 mg once daily for low back and neck pain associated with muscle spasm: a pooled analysis of two randomized, double-blind, parallel-group, placebo-controlled, multicenter studies [poster no. 206]. 24th Annual Meeting of the American Academy of Pain Medicine; 2008 Feb 12-16; Orlando (FL)
7. Cramer MP, Saks SR. Translating safety, efficacy and compliance into economic value for controlled release dosage forms. Pharmacoeconomics 1994 Jun; 5 (6): 482-504
8. Soma [package insert]. Somerset (NJ): MedPointe Pharmaceuticals, 2007
9. Peterson GM, McLean S, Millingen KS. Food does not affect the bioavailability of baclofen. Med J Aust 1985 Jun 24; 142 (13): 689-90
10. Shah J, Wesnes KA, Kovelesky RA, et al. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clin Ther 2006 Sep; 28 (9): 1308-17
11. Locniskar A, Greenblatt DJ, Zinny MA, et al. Absolute bioavailability and effect of food and antacid on diazepam absorption from a slow-release preparation. J Clin Pharmacol 1984 May; 24 (5-6): 255-63
12. Chandra R, Liu P, Breen JD, et al. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. Clin Pharmacokinet 2007; 46 (3): 247-59
13. Wagstaff AJ, Figgitt DP. Extended-release metformin hydrochloride: single-composition osmotic tablet formulation. Treat Endocrinol 2004; 3 (5): 327-32
14. Guay DR. Clinical pharmacokinetics of drugs used to treat urge incontinence. Clin Pharmacokinet 2003; 42 (14): 1243-85
15. Auiler JF, Liu K, Lynch JM, et al. Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) study. Curr Med Res Opin 2002; 18 (5): 311-6
16. Wilder BJ, Leppik I, Hietpas TJ, et al. Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules. Neurology 2001 Aug 28; 57 (4): 582-9
17. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects [online]. Available from http://www.wma.net/e/policy/pdf/17c.pdf [Accessed 2008 Oct 10]